Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date

Br J Haematol. 2020 Jun;189(6):1062-1063. doi: 10.1111/bjh.16780. Epub 2020 May 19.
No abstract available

Keywords: CD8+ T cells; COVID-19; NK cells; SARS-COV-2; cytotoxic cells.

Publication types

  • Letter
  • Review

MeSH terms

  • Betacoronavirus / immunology*
  • Blood Donors*
  • COVID-19
  • Convalescence*
  • Coronavirus Infections* / immunology
  • Coronavirus Infections* / pathology
  • Coronavirus Infections* / therapy
  • Humans
  • Lymphocyte Transfusion*
  • Pandemics*
  • Pneumonia, Viral* / immunology
  • Pneumonia, Viral* / pathology
  • Pneumonia, Viral* / therapy
  • SARS-CoV-2
  • Severity of Illness Index